Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma.

Literature DB >> 17457182

Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma.

Donald L Morton, Alistair J Cochran, John F Thompson.

Abstract

Entities: Disease

Mesh：

Year: 2007 PMID： 17457182 PMCID： PMC1877075 DOI： 10.1097/01.sla.0000261157.79250.16

Source DB: PubMed Journal: Ann Surg ISSN： 0003-4932 Impact factor: 12.969

× No keyword cloud information.

4 in total

1. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial.

Authors: Patrick Twomey
Journal: Ann Surg Date: 2007-01 Impact factor: 12.969

2. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

Authors: Donald L Morton; Alistair J Cochran; John F Thompson; Robert Elashoff; Richard Essner; Edwin C Glass; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; He-jing Wang
Journal: Ann Surg Date: 2005-09 Impact factor: 12.969

3. End points and United States Food and Drug Administration approval of oncology drugs.

Authors: John R Johnson; Grant Williams; Richard Pazdur
Journal: J Clin Oncol Date: 2003-04-01 Impact factor: 44.544

4. Sentinel-node biopsy or nodal observation in melanoma.

Authors: Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal: N Engl J Med Date: 2006-09-28 Impact factor: 91.245

4 in total

6 in total

Review 1. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma.

Authors: Donald L Morton
Journal: Clin Exp Metastasis Date: 2012-06-24 Impact factor: 5.150

2. Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm.

Authors: Friederike Egberts; A Momkvist; J H Egberts; K C Kaehler; M Weichenthal; A Hauschild
Journal: Tumour Biol Date: 2009-12-18

3. Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors: Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal: N Engl J Med Date: 2014-02-13 Impact factor: 91.245